Global Sodium Cromoglycate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Cromoglycate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sodium cromoglycate is an antiallergic molecule that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of bronchial asthma, allergic and exercise-induced asthma, seasonal pollinosis, but does not affect an established asthmatic attack.
Sodium Cromoglycate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Cromoglycate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Inhale and Oral are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Cromoglycate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sodium Cromoglycate key manufacturers include Pfizer, Sanofi, Orion Corporation, Cambrex Corporation, Deafarma S.r.l, Egis Pharmaceuticals PLC, Farmhispania, S.A., Olon Spa and Sifavitor srl, etc. Pfizer, Sanofi, Orion Corporation are top 3 players and held % sales share in total in 2022.
Sodium Cromoglycate can be divided into Solution, Aerosol and Powder,, etc. Solution is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Cromoglycate is widely used in various fields, such as Inhale, Oral and Eye Drops,, etc. Inhale provides greatest supports to the Sodium Cromoglycate industry development. In 2022, global % sales of Sodium Cromoglycate went into Inhale filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Cromoglycate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Pfizer
Sanofi
Orion Corporation
Cambrex Corporation
Deafarma S.r.l
Egis Pharmaceuticals PLC
Farmhispania, S.A.
Olon Spa
Sifavitor srl
Perrigo
Actavis
Allergan
Segment by Type
Solution
Aerosol
Powder
Inhale
Oral
Eye Drops
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Cromoglycate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Cromoglycate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Cromoglycate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Cromoglycate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Cromoglycate introduction, etc. Sodium Cromoglycate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sodium Cromoglycate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Sodium Cromoglycate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Cromoglycate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Inhale and Oral are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Cromoglycate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sodium Cromoglycate key manufacturers include Pfizer, Sanofi, Orion Corporation, Cambrex Corporation, Deafarma S.r.l, Egis Pharmaceuticals PLC, Farmhispania, S.A., Olon Spa and Sifavitor srl, etc. Pfizer, Sanofi, Orion Corporation are top 3 players and held % sales share in total in 2022.
Sodium Cromoglycate can be divided into Solution, Aerosol and Powder,, etc. Solution is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Cromoglycate is widely used in various fields, such as Inhale, Oral and Eye Drops,, etc. Inhale provides greatest supports to the Sodium Cromoglycate industry development. In 2022, global % sales of Sodium Cromoglycate went into Inhale filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Cromoglycate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Pfizer
Sanofi
Orion Corporation
Cambrex Corporation
Deafarma S.r.l
Egis Pharmaceuticals PLC
Farmhispania, S.A.
Olon Spa
Sifavitor srl
Perrigo
Actavis
Allergan
Segment by Type
Solution
Aerosol
Powder
Segment by Application
Inhale
Oral
Eye Drops
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Cromoglycate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Cromoglycate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Cromoglycate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Cromoglycate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Cromoglycate introduction, etc. Sodium Cromoglycate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sodium Cromoglycate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
![](http://localhost/mraccuracy/images/About Report.webp)